<![CDATA[Hormonal contraceptives, particularly the 3-month injectable and implant methods, are widely used by women of reproductive age. Despite their effectiveness, concerns remain regarding their potential impact on hemoglobin (Hb) levels and the risk of anemia. This study aimed to analyze the relationship between the use of 3-month injectable contraceptives and implants with hemoglobin levels, as well as to examine the association between family support and hemoglobin status among women at Kedi Public Health Center. This study employed a quantitative descriptive design with a cross-sectional approach. The sample consisted of 30 women of reproductive age who had used either 3-month injectable contraceptives or implants for at least six months. Data were obtained from medical records and laboratory measurements of hemoglobin levels. Univariate analysis was used to describe respondent characteristics, while bivariate analysis was conducted using Kendall’s tau-b correlation test. The results showed that most respondents were aged 20–35 years and predominantly used the 3-month injectable contraceptive. The majority of respondents (90.0%) had normal hemoglobin levels, while only 10.0% experienced mild anemia. A statistically significant relationship was found between family support and hemoglobin levels (p < 0.05). However, the use of hormonal contraceptive methods did not appear to negatively affect hemoglobin levels. In conclusion, 3-month injectable contraceptives and implants are safe in terms of hemoglobin status, and family support plays an important role in women’s health outcomes.]]>
Copyrights © 2026
